Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and Wuhan University School of Pharmaceutical Sciences, Wuhan 430071, PR China.
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and Wuhan University School of Pharmaceutical Sciences, Wuhan 430071, PR China; State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, PR China; Hubei Engineering Laboratory for Synthetic Microbiology, Wuhan Institute of Biotechnology, Wuhan 430075, PR China.
Metab Eng. 2018 Nov;50:74-84. doi: 10.1016/j.ymben.2018.05.015. Epub 2018 May 28.
There is considerable interest in mining organisms for new natural products (NPs) and in improving methods to overproduce valuable NPs. Because of the rapid development of tools and strategies for metabolic engineering and the markedly increased knowledge of the biosynthetic pathways and genetics of NP-producing organisms, genome mining and overproduction of NPs can be dramatically accelerated. In particular, Streptomyces species have been proposed as suitable chassis organisms for NP discovery and overproduction because of their many unique characteristics not shared with yeast, Escherichia coli, or other microorganisms. In this review, we summarize the methods for genome sequencing, gene cluster prediction, and gene editing in Streptomyces, as well as metabolic engineering strategies for NP overproduction and approaches for generating new products. Finally, two strategies for utilizing Streptomyces as the chassis for NP discovery and overproduction are emphasized.
人们对从生物体中挖掘新的天然产物(NPs)以及改进方法以大量生产有价值的 NPs 非常感兴趣。由于代谢工程工具和策略的快速发展,以及对产生 NPs 的生物体的生物合成途径和遗传学的知识显著增加,基因组挖掘和 NPs 的大量生产可以大大加快。特别是,由于链霉菌具有许多与酵母、大肠杆菌或其他微生物不同的独特特征,因此被提议作为 NP 发现和大量生产的合适底盘生物。在这篇综述中,我们总结了链霉菌的基因组测序、基因簇预测和基因编辑方法,以及 NPs 大量生产的代谢工程策略和生成新产品的方法。最后,强调了利用链霉菌作为 NP 发现和大量生产底盘的两种策略。